Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Genera Biosystems Ltd (GBI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12156
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is a molecular diagnostic test for the detection and genotyping of high risk and low risk types of human papillomavirus that cause cervical cancer or genital warts. GBL uses AmpaSand beads technology to create identifiable clusters of beads that can be distinguished in a conventional flow cytometer. The company provides products to detect influenzaA, influenzaB, influenza A H1N1, influenzaA H5N1, respiratory syncytial virus, human metapneumovirus, adenovirus, rhinovirus, bordetella pertussis, and chlamydophila pneumonia. It collaborates with pathology customers and IVD companies. GBL is headquartered in Melbourne, Victoria, Australia.

Genera Biosystems Ltd (GBI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genera Biosystems Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Genera Biosystems Enters into Distribution Agreement with Beckman Coulter Life Sciences 10
Genera Biosystems Enters into Co-Marketing Agreement with Beckman Coulter Life Sciences 11
Genera Biosystems Enters into Distribution Agreement with Genecell Diagnostics 12
Equity Offering 13
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 13
Genera Biosystems Completes Private Placement Of Shares For US$0.12 Million 14
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 15
Debt Offering 16
Genera Biosystems Raises USD0.5 Million in Second Tranche of Private Placement of Notes 16
Genera Biosystems Raises USD1.6 Million in First Tranche of Private Placement of Notes 17
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 18
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 19
Genera Biosystems Completes Private Placement Of Notes Due 2015 For US$0.34 Million 20
Genera Biosystems Ltd – Key Competitors 21
Genera Biosystems Ltd – Key Employees 22
Genera Biosystems Ltd – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Nov 01, 2018: Genera Biosystems: Quarterly cash flow & business update for 30th June 2018 24
Corporate Communications 25
Nov 30, 2018: Genera Biosystems: changes to the board of directors 25
Other Significant Developments 26
May 01, 2018: Genera Biosystems:Quarterly Cash Flow & Business Update 26
Nov 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 27
Jul 31, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 28
May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017 30
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Genera Biosystems Ltd, Medical Equipment, Key Facts, 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Deals By Market, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genera Biosystems Enters into Distribution Agreement with Beckman Coulter Life Sciences 10
Genera Biosystems Enters into Co-Marketing Agreement with Beckman Coulter Life Sciences 11
Genera Biosystems Enters into Distribution Agreement with Genecell Diagnostics 12
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 13
Genera Biosystems Completes Private Placement Of Shares For US$0.12 Million 14
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 15
Genera Biosystems Raises USD0.5 Million in Second Tranche of Private Placement of Notes 16
Genera Biosystems Raises USD1.6 Million in First Tranche of Private Placement of Notes 17
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 18
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 19
Genera Biosystems Completes Private Placement Of Notes Due 2015 For US$0.34 Million 20
Genera Biosystems Ltd, Key Competitors 21
Genera Biosystems Ltd, Key Employees 22

List of Figures
Genera Biosystems Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vostok New Ventures Ltd (VNV SDB):企業の財務・戦略的SWOT分析
    Summary Vostok New Ventures Ltd (Vostok New Ventures), formerly Vostok Nafta Investment Ltd, is an investment company that identifies and invests in assets. The company carries out partial and complete liquidation of holding and group’s holding companies. It identifies and invests in unlisted compan …
  • NV Bekaert SA:企業のM&A・事業提携・投資動向
    NV Bekaert SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NV Bekaert SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Riot Blockchain Inc (RIOT):医療機器:M&Aディール及び事業提携情報
    Summary Riot Blockchain Inc (Riot Blockchain) builds, operates and supports blockchain technologies. Its primary operations include mining of cryptocurrencies and development of exchange and mining pool platforms. The company focuses on both Bitcoin and Ethereum blockchain ecosystems. Riot Blockchai …
  • Thai Rubber Latex Corp (Thailand) Public Co Ltd (TRUBB):企業の財務・戦略的SWOT分析
    Thai Rubber Latex Corp (Thailand) Public Co Ltd (TRUBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • Covalon Technologies Ltd (COV):医療機器:M&Aディール及び事業提携情報
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercializer of medical products and healthcare technologies. The company offers advanced wound care, infection prevention and perioperative care products. Its wound care products include collagen matrix dressing, collagen m …
  • China Resources Wandong Medical Equipment Co Ltd (600055):医療機器:M&Aディール及び事業提携情報
    Summary China Resources Wandong Medical Equipment Co Ltd (Wandong Medical Equipment), formerly Beijing Wandong Medical Equipment Co Ltd, a subsidiary of Beijing Pharmaceutical Group Co Ltd, is a medical device company that develops and markets medical devices and equipment. The company’s products in …
  • Pilgrim’s Pride Corp (PPC):企業の財務・戦略的SWOT分析
    Pilgrim's Pride Corp (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Corning Inc (GLW):企業の財務・戦略的SWOT分析
    Corning Inc (GLW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CEVA Holdings LLC:戦略・SWOT・企業財務分析
    CEVA Holdings LLC - Strategy, SWOT and Corporate Finance Report Summary CEVA Holdings LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Senzime AB (SEZI)-医療機器分野:企業M&A・提携分析
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • Goodman Group:企業のM&A・事業提携・投資動向
    Goodman Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Goodman Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • TSO3 Inc (TOS):企業の財務・戦略的SWOT分析
    TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • The NorInchukin Bank:企業の戦略・SWOT・財務情報
    The NorInchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The NorInchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MYnd Analytics Inc (MYND):製薬・医療:M&Aディール及び事業提携情報
    Summary MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychia …
  • KLA-Tencor Corporation (KLAC):企業の財務・戦略的SWOT分析
    KLA-Tencor Corporation (KLAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • MolecularMD Corp:医療機器:M&Aディール及び事業提携情報
    Summary MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging s …
  • Aurora Diagnostics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurora Diagnostics LLC (Aurora Diagnostics) is a healthcare service provider that offers hospital and pathology services. The center’s pathology services include gastrointestinal pathology services, heamato-pathology services, dermatology services, urologic pathology, pathology consultation, …
  • G-III Apparel Group Ltd (GIII):企業の財務・戦略的SWOT分析
    Summary G-III Apparel Group, Ltd. (G-III or “the company”) is an apparel and footwear manufacturing company. The company designs, manufactures and markets outerwear, dresses, sportswear, swimwear, women's suits and performance wear, luggage, footwear, and women's handbags, leather goods, and cold we …
  • Adamis Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    Adamis Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Adamis Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆